Dr. Marissa K. Boyle, MD

Dr. Boyle practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Boyle's NPI, 1790224442, was assigned on February 14, 2017. Dr. Boyle graduated from University of Southern California Keck School of Medicine in 2015. Dr. Boyle holds California license 146239.

Dr. Boyle's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Boyle's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Boyle to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boyle practices. Vendor and product names are available with a free account.

Surgery is Dr. Boyle's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Boyle is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Boyle's licenses on file in 2 states: California and New York.

Dmand AI lists mastectomy among the conditions Dr. Boyle treats.

CMS data shows 105 Medicare services from Dr. Boyle across 5 procedure codes in 2024, all of them office visits, for 65 Medicare patients. Medicare paid $9,977 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Dr. Boyle in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 37% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boyle's median patient age at 57, with 97% women.

In 2024, Dr. Boyle wrote 43 Medicare Part D claims for 25 patients. 98% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $47 in total drug cost. In 2022, CMS named 36 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Boyle for performance year 2024, reported as part of a group. Dr. Boyle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of mastectomy by Dr. Boyle, more than 64% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Boyle, published from 2023 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Axilla and Lymph Node Excision. Dr. Boyle has published most often in Ann Surg Oncol. Dr. Boyle's most frequent co-authors are Armando E. Giuliano, FACS, MD, Farin F. Amersi, MD and Christina Noel Weed, MD.

CMS Open Payments shows 3 general payments to Dr. Boyle from 1 drug or device company in 2024. Travel and lodging make up the largest share, 100% of the total. Intuitive Surgical, Inc. paid the most, $690.

Dr. Boyle graduated from University of Southern California Keck School of Medicine in 2015.

Dr. Boyle is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.